![Hellek Bråthen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hellek Bråthen
Nessuna posizione attualmente
Profilo
Hellek Bråthen formerly worked at Nextera AS, as Director, Algeta ASA, as Interim Chief Financial Officer, and Agrinos AS, as Chief Financial Officer.
Mr. Bråthen received his graduate degree from Norwegian School of Economics & Business Administration.
Precedenti posizioni note di Hellek Bråthen
Società | Posizione | Fine |
---|---|---|
ALGETA ASA | Direttore Finanziario/CFO | 13/08/2008 |
Agrinos AS
![]() Agrinos AS Chemicals: AgriculturalProcess Industries Agrinos AS engages in the development, production, and trade of biological crop inputs. Its products include iNvigorate, B-Sure, and Agrinos 5-0-0. The firm focuses on core crops such as corn, potatoes, soybeans, sugarcanes, tomatoes, and wheat; and regional crops such as verries, citrus and fruit trees, coffee, cotton, forage, leafy greens, and vegetables. The company was founded by Kjetil Langland Bøhn, Karl Reiner Fick Rochin, and Aaron Powers in 2009 and is headquartered in Oslo, Norway. | Direttore Finanziario/CFO | - |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Direttore/Membro del Consiglio | - |
Formazione di Hellek Bråthen
Norwegian School of Economics & Business Administration | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Agrinos AS
![]() Agrinos AS Chemicals: AgriculturalProcess Industries Agrinos AS engages in the development, production, and trade of biological crop inputs. Its products include iNvigorate, B-Sure, and Agrinos 5-0-0. The firm focuses on core crops such as corn, potatoes, soybeans, sugarcanes, tomatoes, and wheat; and regional crops such as verries, citrus and fruit trees, coffee, cotton, forage, leafy greens, and vegetables. The company was founded by Kjetil Langland Bøhn, Karl Reiner Fick Rochin, and Aaron Powers in 2009 and is headquartered in Oslo, Norway. | Process Industries |
- Borsa valori
- Insiders
- Hellek Bråthen